Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2016

01.01.2016

Safety and efficacy of second-generation versus first-generation cryoballoons for treatment of atrial fibrillation: a meta-analysis of current evidence

verfasst von: Bhavi Pandya, Azfar Sheikh, Jonathan Spagnola, Soad Bekheit, James Lafferty, Marcin Kowalski

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The newer second-generation cryoballoons (CB-2 or Arc-Adv-CB) have been shown to achieve significantly lower temperature and faster pulmonary vein isolation (PVI) time in comparison with first-generation cryoballoons (CB-1 or Arc-CB). To test the premise that second-generation cryoballoons can improve clinical outcomes in comparison to first-generation cryoballoons in terms of safety and efficacy, we pooled data for systemic review and meta-analyses from all available literature comparing their clinical performance.

Methods

The Cochrane Library, PubMed, Google Scholar, and studies presented at various meetings were searched for any published literature comparing safety and efficacy of the second-generation cryoballoons (Arctic Front Advance cryoballoons) with first-generation cryoballoons (Arctic Front Cryoballoons). A total of ten published studies, with 2310 patients, were included in this meta-analysis with 957 patients in second-generation cryoballoon group and 1237 patients in first-generation cryoballoon group.

Results

The pooled analysis showed significant superiority of second-generation cryoballoons in terms of less procedure time, less fluoroscopic time, and fewer incidences of arrhythmia recurrences compared to first-generation cryoballoons at the cost of higher incidence of persistent and transient phrenic nerve palsy. The differences in the rate of pericardial effusion and incidence of access site complications were not statistically significant.

Conclusions

Second-generation cryoballoons are associated with a shorter procedure time and fluoroscopy time, along with lower arrhythmia recurrence rates, reflecting higher procedure efficacy when compared to first-generation cryoballoons. However, they are also associated with a higher incidence of transient and persistent phrenic nerve palsies with a non-significant difference in rates of access site complications and pericardial effusion.
Literatur
1.
Zurück zum Zitat Piccini, J. P., Lopes, R. D., Kong, M. H., Hasselblad, V., Jackson, K., & Al-Khatib, S. M. (2009). Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. [Meta-analysis research support, Non-U.S. Gov’t]. Circulation. Arrhythmia and Electrophysiology, 2(6), 626–633.CrossRefPubMed Piccini, J. P., Lopes, R. D., Kong, M. H., Hasselblad, V., Jackson, K., & Al-Khatib, S. M. (2009). Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. [Meta-analysis research support, Non-U.S. Gov’t]. Circulation. Arrhythmia and Electrophysiology, 2(6), 626–633.CrossRefPubMed
2.
Zurück zum Zitat Neumann, T., Vogt, J., Schumacher, B., Dorszewski, A., Kuniss, M., Neuser, H., et al. (2008). Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. [Multicenter study]. Journal of the American College of Cardiology, 52(4), 273–278.CrossRefPubMed Neumann, T., Vogt, J., Schumacher, B., Dorszewski, A., Kuniss, M., Neuser, H., et al. (2008). Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. [Multicenter study]. Journal of the American College of Cardiology, 52(4), 273–278.CrossRefPubMed
3.
Zurück zum Zitat Tang, M., Kriatselis, C., Nedios, S., Ye, G., Roser, M., Fleck, E., et al. (2010). A novel cryoballoon technique for mapping and isolating pulmonary veins: a feasibility and efficacy study. [Research support, Non-U.S. Gov’t]. Journal of Cardiovascular Electrophysiology, 21(6), 626–631.CrossRefPubMed Tang, M., Kriatselis, C., Nedios, S., Ye, G., Roser, M., Fleck, E., et al. (2010). A novel cryoballoon technique for mapping and isolating pulmonary veins: a feasibility and efficacy study. [Research support, Non-U.S. Gov’t]. Journal of Cardiovascular Electrophysiology, 21(6), 626–631.CrossRefPubMed
4.
Zurück zum Zitat Coulombe, N., Paulin, J., & Su, W. (2013). Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. [Research support, Non-U.S. Gov’t]. Journal of Cardiovascular Electrophysiology, 24(8), 919–925.CrossRefPubMed Coulombe, N., Paulin, J., & Su, W. (2013). Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. [Research support, Non-U.S. Gov’t]. Journal of Cardiovascular Electrophysiology, 24(8), 919–925.CrossRefPubMed
5.
Zurück zum Zitat Casado-Arroyo, R., Chierchia, G. B., Conte, G., Levinstein, M., Sieira, J., Rodriguez-Manero, M., et al. (2013). Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon. Heart Rhythm, 10(9), 1318–1324.CrossRefPubMed Casado-Arroyo, R., Chierchia, G. B., Conte, G., Levinstein, M., Sieira, J., Rodriguez-Manero, M., et al. (2013). Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon. Heart Rhythm, 10(9), 1318–1324.CrossRefPubMed
6.
Zurück zum Zitat Martins, R. P., Hamon, D., Cesari, O., Behaghel, A., Behar, N., Sellal, J. M., et al. (2014). Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm, 11(3), 386–393.CrossRefPubMed Martins, R. P., Hamon, D., Cesari, O., Behaghel, A., Behar, N., Sellal, J. M., et al. (2014). Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm, 11(3), 386–393.CrossRefPubMed
7.
Zurück zum Zitat Straube, F., Dorwarth, U., Vogt, J., Kuniss, M., Heinz Kuck, K., Tebbenjohanns, J., et al. (2014). Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. In Europace (Vol. 16, pp. 1434–1442, Vol. 10). England: Published on behalf of the European Society of Cardiology The Author 2014. For permissions please email: journals.permissions@oup.com. Straube, F., Dorwarth, U., Vogt, J., Kuniss, M., Heinz Kuck, K., Tebbenjohanns, J., et al. (2014). Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. In Europace (Vol. 16, pp. 1434–1442, Vol. 10). England: Published on behalf of the European Society of Cardiology The Author 2014. For permissions please email: journals.permissions@oup.com.
8.
Zurück zum Zitat Liu, J., Kaufmann, J., Kriatselis, C., Fleck, E., & Gerds-Li, J. H. (2015). Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation. Pacing and Clinical Electrophysiology, 38(1), 129–135.CrossRefPubMed Liu, J., Kaufmann, J., Kriatselis, C., Fleck, E., & Gerds-Li, J. H. (2015). Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation. Pacing and Clinical Electrophysiology, 38(1), 129–135.CrossRefPubMed
9.
Zurück zum Zitat Greiss, H., Berkowitsch, A., Wojcik, M., Zaltsberg, S., Pajitnev, D., Deubner, N., et al. (2015). The impact of left atrial surface area and the second generation cryoballoon on clinical outcome of atrial fibrillation cryoablation. Pacing and Clinical Electrophysiology, 38, 815–824.CrossRefPubMed Greiss, H., Berkowitsch, A., Wojcik, M., Zaltsberg, S., Pajitnev, D., Deubner, N., et al. (2015). The impact of left atrial surface area and the second generation cryoballoon on clinical outcome of atrial fibrillation cryoablation. Pacing and Clinical Electrophysiology, 38, 815–824.CrossRefPubMed
10.
Zurück zum Zitat Furnkranz, A., Bordignon, S., Schmidt, B., Perrotta, L., Dugo, D., De Lazzari, M., et al. (2015). Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients. In Europace (Vol. 17, pp. 574–578, Vol. 4). England: Published on behalf of the European Society of Cardiology The Author 2015. For permissions please email: journals.permissions@oup.com. Furnkranz, A., Bordignon, S., Schmidt, B., Perrotta, L., Dugo, D., De Lazzari, M., et al. (2015). Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients. In Europace (Vol. 17, pp. 574–578, Vol. 4). England: Published on behalf of the European Society of Cardiology The Author 2015. For permissions please email: journals.permissions@oup.com.
11.
Zurück zum Zitat Aryana, A., Morkoch, S., Bailey, S., Lim, H. W., Sara, R., d’Avila, A., et al. (2014). Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first- and second-generation cryoballoon: a retrospective comparative study with follow-up outcomes. Journal of Interventional Cardiac Electrophysiology, 41(2), 177–186.CrossRefPubMed Aryana, A., Morkoch, S., Bailey, S., Lim, H. W., Sara, R., d’Avila, A., et al. (2014). Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first- and second-generation cryoballoon: a retrospective comparative study with follow-up outcomes. Journal of Interventional Cardiac Electrophysiology, 41(2), 177–186.CrossRefPubMed
12.
Zurück zum Zitat Aytemir, K., Gurses, K. M., Yalcin, M. U., Kocyigit, D., Dural, M., Evranos, B., et al. (2015). Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoondagger. In Europace (Vol. 17, pp. 379–387, Vol. 3). England: published on behalf of the European Society of Cardiology The Author 2014. For permissions please email: journals.permissions@oup.com. Aytemir, K., Gurses, K. M., Yalcin, M. U., Kocyigit, D., Dural, M., Evranos, B., et al. (2015). Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoondagger. In Europace (Vol. 17, pp. 379–387, Vol. 3). England: published on behalf of the European Society of Cardiology The Author 2014. For permissions please email: journals.permissions@oup.com.
13.
Zurück zum Zitat Chan, N. Y., Yuen, H. C., Chu, P. S., Choy, C. C., Chow, H. F., Fong, H. F., et al. (2013). Inner lumen mapping catheter-facilitated big cryoballoon treatment for atrial fibrillation shortens procedural duration and fluoroscopic exposure with comparable mid-term efficacy. Journal of Interventional Cardiac Electrophysiology, 37(2), 169–177.CrossRefPubMed Chan, N. Y., Yuen, H. C., Chu, P. S., Choy, C. C., Chow, H. F., Fong, H. F., et al. (2013). Inner lumen mapping catheter-facilitated big cryoballoon treatment for atrial fibrillation shortens procedural duration and fluoroscopic exposure with comparable mid-term efficacy. Journal of Interventional Cardiac Electrophysiology, 37(2), 169–177.CrossRefPubMed
14.
Zurück zum Zitat Furnkranz, A., Bordignon, S., Schmidt, B., Gunawardene, M., Schulte-Hahn, B., Urban, V., et al. (2013). Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. Journal of Cardiovascular Electrophysiology, 24(5), 492–497.CrossRefPubMed Furnkranz, A., Bordignon, S., Schmidt, B., Gunawardene, M., Schulte-Hahn, B., Urban, V., et al. (2013). Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. Journal of Cardiovascular Electrophysiology, 24(5), 492–497.CrossRefPubMed
15.
Zurück zum Zitat Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. In Europace (Vol. 14, pp. 528–606, Vol. 4). England. Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. In Europace (Vol. 14, pp. 528–606, Vol. 4). England.
16.
Zurück zum Zitat Tzou, W. S., Marchlinski, F. E., Zado, E. S., Lin, D., Dixit, S., Callans, D. J., et al. (2010). Long-term outcome after successful catheter ablation of atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(3), 237–242. United States.CrossRefPubMed Tzou, W. S., Marchlinski, F. E., Zado, E. S., Lin, D., Dixit, S., Callans, D. J., et al. (2010). Long-term outcome after successful catheter ablation of atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(3), 237–242. United States.CrossRefPubMed
17.
Zurück zum Zitat Wokhlu, A., Hodge, D. O., Monahan, K. H., Asirvatham, S. J., Friedman, P. A., Munger, T. M., et al. (2010). Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. Journal of Cardiovascular Electrophysiology, 21(10), 1071–1078. United States: 2010 Wiley Periodicals, Inc.CrossRefPubMed Wokhlu, A., Hodge, D. O., Monahan, K. H., Asirvatham, S. J., Friedman, P. A., Munger, T. M., et al. (2010). Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. Journal of Cardiovascular Electrophysiology, 21(10), 1071–1078. United States: 2010 Wiley Periodicals, Inc.CrossRefPubMed
18.
Zurück zum Zitat Lim, H. W., Cogert, G. A., Cameron, C. S., Cheng, V. Y., & Sandler, D. A. (2014). Atrioesophageal fistula during cryoballoon ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 25(2), 208–213.CrossRefPubMed Lim, H. W., Cogert, G. A., Cameron, C. S., Cheng, V. Y., & Sandler, D. A. (2014). Atrioesophageal fistula during cryoballoon ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 25(2), 208–213.CrossRefPubMed
19.
Zurück zum Zitat Sacher, F., Monahan, K. H., Thomas, S. P., Davidson, N., Adragao, P., Sanders, P., et al. (2006). Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. Journal of the American College of Cardiology, 47(12), 2498–2503.CrossRefPubMed Sacher, F., Monahan, K. H., Thomas, S. P., Davidson, N., Adragao, P., Sanders, P., et al. (2006). Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. Journal of the American College of Cardiology, 47(12), 2498–2503.CrossRefPubMed
Metadaten
Titel
Safety and efficacy of second-generation versus first-generation cryoballoons for treatment of atrial fibrillation: a meta-analysis of current evidence
verfasst von
Bhavi Pandya
Azfar Sheikh
Jonathan Spagnola
Soad Bekheit
James Lafferty
Marcin Kowalski
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2016
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-015-0075-4

Weitere Artikel der Ausgabe 1/2016

Journal of Interventional Cardiac Electrophysiology 1/2016 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.